Alterity Announces New US Patent to Expand its Portfolio of Compounds for Neurodegenerative Diseases including Alzheimer’s and Parkinson’s August 4, 2021August 16, 2022
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024 April 10, 2024April 10, 2024